C-HMG6Centaura
Human Artificial Chromosome, gene editing, gene therapy
editinggene therapy
Loading
Загрузка раздела...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-HMG6
C-HMG6C-HMG6Human Artificial Chromosome, gene editing, gene therapy
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Centaura Human Artificial Chromosome, gene editing, gene therapy
Centaura is developing a Human Artificial Chromosome platform for massive gene editing and multi-gene delivery. The site says the platform can accept, deliver, and express genes with therapeutic or bioproduction functions, including biologics, viral vectors, enzymes, therapeutic RNAs, CRISPR/Cas proteins, guide RNAs, and biosensors. Centaura states that it can integrate large DNA sequences into cells reliably, safely, and without mediating an immune response, with the goal of overcoming lifespan barriers.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Centaura — Far from goals · Bottom quartile. Derived deterministically from 1 extracted project(s). Most-advanced status: undisclosed. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic